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Abstract   24 
Viruses in the family Coronaviridae, with the Nidovirus order, are etiologic agents of a range of 25 
human and animal diseases, including both mild and severe respiratory disease in humans. 26 
These viruses encode conserved replicase and structural proteins, and more diverse accessory 27 
proteins in the 3’ end of their genomes that often act as host cell antagonists. We have 28 
previously shown that 2’,5’ phosphodiesterases (PDE)  encoded by the prototypical 29 
Betacoronavirus, mouse hepatitis virus (MHV), Middle East respiratory syndrome-associated 30 
coronavirus antagonize the oligoadenylate – ribonuclease L (OAS-RNase L) pathway. Here we 31 
report that additional coronavirus superfamily members including lineage A betacoronaviruses 32 
and toroviruses infecting both humans and animals encode 2’,5’ PDEs capable of antagonizing 33 
RNase L. We used a chimeric MHV system, in which exogenous PDEs were expressed from an 34 
MHV backbone lacking a functional NS2 protein (MHVMut), its endogenous RNase L antagonist. 35 
In this system, we found that 2’,5’ PDEs encoded by human coronavirus HCoV-OC43 (OC43), 36 
an agent of the common cold, human enteric coronavirus (HECoV), equine coronavirus (ECoV), 37 
and equine torovirus-Berne (BEV) are enzymatically active, rescue replication of MHVMut in bone 38 
marrow-derived macrophages and inhibit RNase L-mediated rRNA degradation in these cells. 39 
Additionally, PDEs encoded by OC43 and BEV rescue MHVMut replication and restore 40 
pathogenesis in WT B6 mice. This finding expands the range of viruses known to encode 41 
antagonists of the potent OAS-RNase L antiviral pathway, highlighting its importance in a range 42 
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Viruses in the family Coronaviridae include important human and animal pathogens, including 51 
the recently emerged SARS-CoV and MERS-CoV. We have shown previously that two viruses 52 
within the genus Betacoronavirus murine coronavirus (MHV) and MERS-CoV, encode 2’,5’ 53 
phosphodiesterases (PDEs) that antagonize the OAS-RNase L pathway and report here that 54 
these proteins are furthermore conserved among additional coronavirus superfamily members 55 
including lineage A betacoronaviruses and toroviruses and suggesting they may play critical 56 
roles in pathogenesis. As there are no licensed vaccines or effective antivirals against human 57 
coronaviruses and few against those infecting animals, identifying viral proteins contributing to 58 
virulence can inform therapeutic development. Thus, this work demonstrates that a potent 59 
antagonist of host antiviral defenses is encoded by multiple and diverse viruses within 60 
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Coronaviruses (CoV) and closely related toroviruses (ToV) are well known agents of disease in 64 
mammals, including humans. Coronaviruses and toroviruses, members of the family 65 
Coronaviridae, within the Nidovirus order, contain positive sense single stranded (ss)RNA 66 
genomes, the longest known RNA genomes ranging from 28-31kb (1).  The first two thirds of 67 
their genomes encodes the replicase proteins, which include the viral RNA-dependent RNA 68 
polymerase and numerous non-structural proteins (NSPs), which are required for replication 69 
and in some cases have host immune antagonist activities (2) 70 
.  The structural proteins are encoded in the 3’ third of the genome and consist of spike (S), 71 
small membrane protein (E), membrane (M), nucleocapsid (N) and sometimes hemagglutinin-72 
esterase (HE). Interspersed among the structural genes are diverse genes encoding accessory 73 
proteins that are not essential for replication but are believed to be required for virulence in vivo 74 
(1). 75 
 76 
Mouse hepatitis virus (MHV) is a lineage A Betacoronavirus and the prototypical CoV. MHV 77 
encodes the accessory protein NS2 which was previously identified as a 2-His (H) 78 
phosphoesterase (2H-PE) superfamily member (3) that we have demonstrated has 2’,5’-79 
phosphodiesterase (PDE) activity that antagonizes host interferon (IFN) signaling via 80 
antagonism of the 2’,5’-oligoadenylate synthetase (OAS)-ribonuclease (RNase) L pathway (4). 81 
Upon sensing double stranded (ds)RNA, OAS synthesizes 2’,5’-oligoadenylates (2-5A) which 82 
catalyze the activation of RNase L via homodimerization. RNase L subsequently cleaves host 83 
and viral ssRNA leading to termination of protein synthesis and subsequent apoptosis (5).  NS2 84 
cleaves 2-5A thus preventing the activation of RNase L.  NS2 is a critical determinant of MHV 85 
strain A59 (A59) liver tropism in C57Bl/6 (B6) mice and is required for the virus to cause 86 
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phosphodiesterase is unable to antagonize the OAS-RNase L pathway in the liver of mice. 88 
Infection with this virus does not result in hepatitis and NS2Mut replication is reduced at least 89 
10,000 fold compared to wild-type A59. However, in mice genetically deficient for RNase L 90 
(RNase L-/-) NS2Mut replicates to wild-type levels and causes hepatitis (4). 91 
 92 
As might be expected of antagonists of a potent innate antiviral pathway, 2’,5’ PDEs are not a 93 
host evasion mechanism unique to MHV. We recently showed that the NS4b accessory protein 94 
of MERS-CoV and related bat coronaviruses, all lineage C betacoronaviruses, encode the NS4b 95 
accessory proteins with 2’,5’-PDE activity (6). Additionally, unrelated group A rotaviruses 96 
encode a PDE in the C-terminal domain of the VP3 structural protein (7). We show here that 97 
lineage A betacoronaviruses closely related to MHV, including the human respiratory HCoV-98 
OC43 (OC43), human enteric CoV-4408 (HECoV), equine ECoV-NC99 (ECoV), and porcine 99 
hemagglutinating encephalomyelitis virus (PHEV), as well as the more distantly related equine 100 
torovirus (EToV)-Berne (BEV) also encode NS2 homologs with predicted PDE activity. We 101 
found that these proteins do possess enzymatic 2’,5’-PDE activity that is capable of 102 
antagonizing RNase L (with the exception of the PHEV NS2) and thus countering a potent host 103 
antiviral response, suggesting that PDE mediated OAS-RNase L antagonism is an important 104 
virulence strategy for lineage A betacoronaviruses and toroviruses. 105 
 106 
Material and Methods 107 
 108 
Cell lines and mice. Murine fibroblast L2 (L2), murine 17 clone 1 (17Cl1) and baby hamster 109 
kidney cells expressing MHV receptor (BHK-R) were cultured as previously described (8,9). 110 
C57Bl/6 (B6) mice were originally procured from the National Cancer Institutes mouse 111 
repository, and RNase L-/- mice on a B6 genetic background were derived by Dr. Robert 112 
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experiments involving mice were approved by the Institutional Animal Care and Use Committee 114 
at the University of Pennsylvania.  Primary bone marrow derived macrophages (BMM) were 115 
derived from marrow harvested from the hind limbs (tibia and femur) of four to six week old B6 116 
or RNase L-/- mice as described previously (4,11). Cells were cultured in DMEM (Gibco) 117 
supplemented with 10% FBS (Hyclone) and 20% L929 cell-conditioned media for 6 days before 118 
infection.   119 
 120 
Plasmids. NS2 genes from lineage A betacoronaviruses OC43, HECV-4408, ECoV-NC99 121 
NC99, PHEV and pp1a-carboxyterminal domain (CTD) from the torovirus Berne were 122 
synthesized and cloned into pUC57 by BioBasic yielding pUC-OC43NS2, pUC-HECVNS2, 123 
pUC-ECoVNS2, pUC-PHEVNS2 and pUC-pp1a. The second catalytic His to Arg substitutions 124 
were made by site directed mutagenesis in all plasmids resulting in pUC-OC43NS2H129R, pUC-125 
HECVNS2H129R, pUC-NC99NS2H129R, pUC-PHEVNS2H129R and pUC-pp1aH4516R. Select genes 126 
were subsequently subcloned into the pMal parallel-2 expression vector resulting in pMAL-127 
OC43NS2, pMAL-OC43NS2H129R, pMAL-PHEVNS2, pMAL-PHEVNS2H129R, pMAL-pp1a and 128 
pMAL-pp1aH4516R.  MHV NS2 and NS2H129R had been previously cloned into pMAL-c2  (4). 129 
 130 
Purification of recombinant PDEs from E. coli and FRET assay. MBP-PDE fusion proteins 131 
were expressed from pMAL-plasmids in BL21 T7 expression competent E. coli (NEB, Inc., 132 
Ipswich, MA) and purified by affinity chromatography followed by ion exchange chromatography 133 
on MonoQ GL10/100 using a NaCl gradient from 0 to 1 M in 20 mM NaCl as previously 134 
described (4,12). The integrity and the purity of the purified MBP fusion proteins were 135 
determined by SDS-PAGE Coomassie Blue R250 staining. The extent of purity was similar for 136 
all of the enzymes as accessed by SDS-PAGE analysis. To assess enzymatic activity, purified 137 
proteins  [10 μM MBP (420 µg/ml) as control or 1 μM OC43 (75 µg/ml);  BEV (60 µg/ml) PHEV 138 
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HEPES [pH 7.2], 10 mM MgCl2, 1 mM dithiothreitol) were incubated at 30° with (2’-5’)p3A3 (2-140 
5A). After one hour, reactions were stopped by heat inactivation at 95° for 3 min followed by 30 141 
min centrifugation at 20,000 X g (4°) and supernatants carefully removed. A fluorescent 142 
resonance energy transfer (FRET) assay was used to assess enzymatic activity by measuring 143 
the amount of uncleaved, intact 2-5A left in the reaction, as previously described (13). The 144 
abilities of recombinant enzyme to degrade 2-5A were determined by a FRET based RNase L 145 
activation assay using an authentic 2-5A (2’,5’-p3A3) trimer as described earlier (4, 6, 13, 14).  146 
Assays were performed three times in triplicate using two separate enzyme preparations. 147 
  148 
Viruses and chimeric recombinant virus construction. Wild-type MHV strain A59 and 149 
mutant NS2H126R (referred to as MHV and MHVMut in the data shown herein) were described 150 
previously (14). The chimeric viruses were constructed based on the infectious cDNA clone 151 
icMHV-A59 (8,15). The wild-type and mutant PDEs genes were PCR amplified from the pUC 152 
plasmids constructed above with primers bearing SalI and NotI restricting sites. After purification 153 
and digestion with SalI and NotI, the fragments were cloned into icMHV-A59 fragment G, with 154 
an NS2H126R mutation, as previously described (14), and confirmed by DNA sequencing. The 155 
full-length A59 genome cDNA was assembled, and the recombinant viruses were recovered in 156 
BHK-R cells as previously described (8,14,15). When virus cytopathology was observed, virus 157 
was plaque purified from the supernatant and amplified on 17CL-1 cells for use.  The pairs of 158 
chimeric viruses expressing WT and mutant PDEs were named by the source of the PDE, 159 
OC43 & OC43Mut, HECoV & HECoVMut, PHEV & PHEVMut, ECoVMut & ECoV and BEV & BEVMut. 160 
The PDE gene and flanking regions were amplified by PCR from the cloned chimeric virus 161 
genomes and the sequences verified. The primers used for sequencing were Fns4 (5’-162 
TTGTTGTGATGAGTATGGAG)  which maps 136 nucleotides upstream of the ATG start codon 163 
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downstream of the PDE ORF The regions sequenced region includes the SalI and NotI 165 
restriction sites as well as the transcription regulatory sequence (TRS) for ORF4 and ORF5a.  166 
 167 
Chimeric MHV infections of bone marrow derived macrophages (BMM). BMM were mock 168 
infected or infected at a multiplicity of infection (MOI) of 1 PFU/cell (in triplicate) and allowed to 169 
adsorb for 1 hour at 37 °C. Cultures were washed with PBS (3 times) and fed with medium. At 170 
the times indicated, cells were lysed and analyzed for degradation of RNA (described below) or 171 
supernatants were harvested for quantification of viral titers by plaque assay on L2 cells (14). 172 
 173 
Immunoblotting. L2 cells were infected with MHV or chimeric viruses (MOI=1PFU/cell). At 10 174 
hours post infection, cells were lysed in nonidet P-40 (NP-40) buffer (1% NP-40, 2 mM EDTA, 175 
10% glycerol, 150 mM NaCl and 50 mM Tris pH 8.0) containing protease inhibitors (Roche). 176 
Protein concentrations were measured using a DC protein assay kit (Bio-Rad). Supernatants 177 
were mixed 3:1 with 4X SDS-PAGE sample buffer. Samples were boiled, separated by 4-15% 178 
SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes. Blots were blocked 179 
with 5% nonfat milk and probed with the following antibodies: anti-Flag M2 mice monoclonal 180 
antibody (Agilent, 1:1000); anti MHV nucleocapsid mouse monoclonal antibody (a gift from Dr. 181 
Julian Leibowitz; 1:400) and anti GAPDH mouse monoclonal antibody (Thermo Scientific, 182 
1:1000). Anti-mouse HRP (Santa Cruz; 1:5000) secondary antibodies were used to detect the 183 
primary antibodies. The blots were visualized using Super Signal West Dura Extended Duration 184 
Substrate (Thermo Scientific). Blots were probed sequentially with antibodies with blots being 185 
stripped between antibody treatments. 186 
 187 
Analysis of RNase L mediated rRNA degradation. RNA was harvested from B6 WT BMM 188 
infected with MHV and chimeric viruses encoding WT and catalytically inactive PDEs at the 189 
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analyzed with an Agilent BioAnalyzer 2100 on a eukaryotic total RNA nanochip. The 191 
BioAnalyzer converts the electropherogram generated for each sample into the pseudogel as 192 
depicted in Fig 6 (4). 193 
 194 
Replication in mice. Four week old B6 or RNase L-/- mice (5-7) were anesthetized with 195 
isoflurane (Abbott Laboratories; Chicago, IL) and inoculated intrahepatically with 2000 PFU in 196 
50 μL of DPBS (Gibco) containing 0.75% bovine serum albumin (Sigma). Mice were euthanized 197 
with CO2, perfused with DPBS (Gibco) and livers harvested at day five post inoculation.  Part of 198 
the liver was fixed for histology below and the rest was homogenized and viral titers were 199 
determined by plaque assay of liver homogenates on L2 cells (16). A piece of each liver was 200 
fixed overnight in 4% paraformaldehyde, embedded in paraffin and sectioned. Sections were 201 
stained with hematoxylin and eosin (H&E) or alternatively blocked with 10% normal donkey 202 
serum and immunostained with a 1:20 dilution of a monoclonal antibody against MHV 203 
nucleocapsid (N) protein (1:1000 dilution). Staining was developed using avidin-biotin-204 




Alignment and modeling of coronavirus and torovirus NS2 proteins. To determine whether 209 
the MHV-related betacoronaviruses encode proteins with 2’,5’-PDE activity we first analyzed the 210 
primary amino acid sequence of the NS2 proteins from OC43, HECoV, ECoV-NC99, PHEV and 211 
the pp1a-CTD of BEV. While the NS2 homologs are encoded within ORF2a, the PDE of BEV is 212 
encoded at the 3’ end of the ORF1a and processed from the pp1a polyprotein (2). All of these 213 
proteins contain two conserved HxS/Tx motifs spaced by ~80 residues, where x is any 214 
hydrophobic residue, characteristic of 2H-phosphoesterase superfamily proteins (3,4,14) (Fig 1). 215 
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NS2 proteins, similar to rotavirus VP3-CTD PDEs (14,17). We further entered the primary amino 217 
acid sequence of these proteins into Phrye2 to predict their tertiary structures (Fig 2).  All of 218 
these proteins scored highly for homology with the published structure of the A-kinase 219 
anchoring protein 7 (AKAP7) central domain (CD) (18), a previously identified host-encoded 2H-220 
PE with 2’,5’-PDE (7). We have previously shown that the MHV NS2 and group A rotavirus 221 
(RVA) VP3 proteins, also structural homologs of AKAP7 CD, exhibit 2’,5’ PDE activity and can 222 
antagonize RNase L (4,7,14).  223 
 224 
Coronavirus and torovirus putative 2’,5’ PDEs are enzymatically active and cleave 2-5A. 225 
To determine whether the predicted Nidovirus PDEs (OC43, BEV, PHEV) are enzymatically 226 
active, the genes encoding them as well as their corresponding mutants with an Arg substitution 227 
of the second predicted catalytic His residue were expressed in Escherichia coli as maltose 228 
binding protein (MBP) fusion proteins and purified by affinity chromatography followed by ion 229 
exchange chromatography and size exclusion chromatography as described in Materials and 230 
Methods (4). Purified wild type or catalytic mutant proteins were incubated with 2-5A substrate 231 
and an indirect fluorescent resonance energy transfer (FRET) assay was used to assess 232 
activation of RNase L, in which higher RLUs represent active RNase L as described in Materials 233 
and Methods and in detail previously (13). MHV NS2 was utilized as a positive control for 234 
inhibition of RNase L (Fig 3). OC43 and BEV proteins reduced RNase L activation to a similar 235 
degree as MHV NS2, while PHEV NS2 was significantly less active. The mutant proteins 236 
containing a His  Arg mutation in the second catalytic motif did not inhibit RNase L, as 237 
expected and consistent with previously results describing MHV NS2 (4).  238 
 239 
Coronavirus and Torovirus PDEs inhibit RNase L when are expressed from a chimeric 240 
MHV NS2 mutant backbone To investigate whether the NS2 proteins of OC43, HECoV, ECoV, 241 
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viruses expressing each exogenous PDE from ORF4 (encoding NS4a, 4b) of an MHV backbone 243 
(Fig 4). The MHV-A59 backbone we utilized encodes H126R substitution in NS2 (MHVMut  244 
referred to in literature as NS2H126R) that abrogates its enzymatic activity and its ability to 245 
antagonize RNase L. MHVMut exhibits minimal replication in primary bone marrow-derived 246 
macrophages (BMM) or in vivo (4). The chimeric viruses we constructed express either the 247 
exogenous PDE protein or its catalytic mutant from the ORF4 locus of MHV, which is 248 
dispensable for MHV replication in vitro and in vivo (19).  Each exogenous protein was 249 
constructed with a C-terminal Flag-tag to allow verification of expression from the chimeric 250 
viruses.  251 
 252 
To assess expression of PDEs by western blot, we infected L2 cells with the chimeric viruses 253 
and harvested protein lysates at 10 hours post-infection (hpi). We probed for the exogenous 254 
PDEs using a primary antibody directed against the Flag-tag, and utilized GAPDH as a loading 255 
control (Fig 5). The OC43, HECV and ECov PDEs were detectable by western blot at a high 256 
level of abundance, while detection of BEV pp1-CTD expression was less robust. PHEV NS2 257 
expression from multiple viral clones as well as the swarm of uncloned recombinant virus could 258 
not be detected by western blot.  259 
 260 
 261 
Exogenous coronavirus and torovirus PDEs rescue replication of MHVMut in primary B6 262 
BMMs through inhibition of RNase L activation. To determine if the exogenous PDEs can 263 
antagonize RNase L in the context of infection, we infected BMMs from WT B6 and RNase L-/- 264 
mice with MHV, MHVMut and the chimeric viruses and measured replication by plaque assay at 265 
6, 9, 12, and 24 hpi. As expected, MHVMut  is significantly attenuated in WT BMMs but replicates 266 
to equivalent titers as MHV in RNase L-/- BMMs (Fig 6A). All of the chimeric viruses encoding 267 
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A59 in B6 BMMs, indicating that these proteins effectively compensate for an inactive NS2H126R 269 
in MHV (Fig 4B-E). In contrast, and similarly to MHVMut, the chimeras expressing catalytically 270 
inactive exogenous PDEs fail to replicate robustly in B6 BMMs but do replicate efficiently in 271 
RNase L-/- BMMs (Fig 6A-E). The chimeric virus encoding PHEV NS2 were not assessed for 272 
replication in BMMs due to our inability to confirm its expression (Figure 5). 273 
 274 
To directly link antagonism of RNase L to the ability of the exogenous PDEs to rescue MHVMut 275 
replication, we assessed rRNA degradation in infected cells by Bioanalyzer. We have previously 276 
used this assay to demonstrate that MHV NS2, but not NS2H126R, inhibits RNase L-mediated 277 
RNA degradation, and that a deficiency in RNase L obviates the requirement for NS2 in MHV 278 
replication (4). We infected B6 WT and RNase L-/- BMMs with MHV and the chimeric viruses and 279 
harvested total RNA 9 hpi. We ran the total RNA on a Bioanalyzer to visualize the integrity of 280 
rRNA during infection with MHV and the chimeric viruses. MHV and the chimeric viruses 281 
encoding exogenous PDEs encoded by MHV, OC43, HECoV, ECoV and BEV prevented rRNA 282 
degradation in B6 WT BMMs, while the corresponding catalytically inactive PDEs failed to do so 283 
(Fig 6F). This directly links the ability of the exogenous PDEs to rescue MHVMut replication to 284 
their antagonism of RNase L activation.  285 
 286 
OC43 NS2 and BEV pp1a-CTD restore MHVMut replication and pathogenesis in vivo. MHV 287 
causes profound hepatitis and associated liver pathology in B6 mice, with its liver replication 288 
and pathogenesis dependent on NS2-mediated antagonism of RNase L (Fig 7) (4). To 289 
determine whether exogenous viral PDEs can rescue replication and restore pathogenesis to 290 
MHVMut, we infected B6 and RNase L-/- mice with MHV, MHVMut and the chimeric viruses 291 
expressing either WT or catalytic mutant PDEs from OC43 (NS2) and BEV (pp1a-CTD). Five 292 
days post-infection, at the time of peak titer, the mice were sacrificed and livers harvested for 293 
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NS2 or BEV pp1-CTD replicated robustly in the liver, similarly to MHV. In contrast, and like 295 
MHVMut, the chimeric viruses expressing mutant OC43 NS2 (Fig 7B) or BEV pp1a-CTD (Fig 7C) 296 
are dramatically restricted, replicating only to titers below or just above the limit of detection, 297 
whereas all of the chimeric viruses replicated robustly in the livers of RNase L-/- mice (Fig 7A-C).  298 
 299 
To assess hepatitis in these infected mice, livers sections were assessed for viral antigen and 300 
pathological changes. Like A59, chimeric viruses expressing WT OC43 NS2 or BEV pp1a-CTD 301 
caused hepatitis in B6 mice, indicated by pathologic foci in H&E stained livers, with viral antigen 302 
staining widely observed (Fig 7D,E). Chimeric viruses expressing catalytically inactive OC43 303 
NS2 or BEV pp1a-CTD did not cause liver pathology in B6 mice and viral antigen was absent, 304 
consistent with the lack of replication (Fig 7D,E). In RNase L-/- mice, all of the chimeric viruses 305 
replicated robustly and caused pathology similar to MHV A59 (Fig 7D,E), further demonstrating 306 
that the restriction of the viruses expressing mutant PDEs in B6 mice is RNase L-mediated and 307 
that the exogenous PDEs function equivalently to MHV NS2.   308 
 309 
Discussion 310 
We have previously demonstrated 2-5A cleavage and RNase L antagonism by 2’,5’ PDEs 311 
encoded by a lineage A and a lineage C betacoronavirus (MHV and MERS-CoV respectively) 312 
and group A rotaviruses as well as by cellular AKAP7 CD (4,6,7,14). Here, we extend these 313 
findings to show that additional lineage A betacoronaviruses as well as a related torovirus family 314 
member encode 2’,5’ PDEs capable of antagonizing RNase L by cleaving 2-5A. The presence 315 
of genes encoding these proteins in multiple lineage A betacoronaviruses suggests that this 316 
gene was acquired by an ancient common ancestor of this lineage. Whether this virus was also 317 
ancestral to toroviruses and lineage C betacoronaviruses, or whether 2’,5’ PDEs were acquired 318 
by viruses in multiple independent events is unclear. The maintenance of this highly conserved 319 
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essential function in the diverse natural hosts of these viruses, spanning multiple mammalian 321 
families. Our finding of a homologous PDE in some groups of rotaviruses (14), a virus family, 322 
unrelated to coronaviruses is intriguing. A coronavirus recently isolated from bats was found to 323 
encode a protein likely to have originated from a bat orthoreovirus, which like rotaviruses has a 324 
dsRNA genome, suggesting the possibility of recombination between coronavirus and a dsRNA 325 
virus (20). Further support for this idea comes from a recent report of isolation of a MERS like 326 
coronavirus and a rotavirus in the feces of Korean bats (21). Additionally, the viruses encoding 327 
the PDEs we have described here infect different tissues within their hosts (1,22,23), indicating 328 
that RNase L antagonism may be required for robust replication in diverse cell types. For 329 
example, although MHV is hepatotropic, OC43 infects the upper airway, while other PDEs 330 
described here are encoded by enterotropic viruses (1,22,23). 331 
 332 
The PDEs encoded by OC43, HECoV, ECoV and BEV antagonized RNase L and rescued 333 
replication of MHVMut in primary WT B6 BMMs, indicating that not only are they enzymatically 334 
active 2’,5’ PDEs, but that they functionally compensate for an inactive MHV NS2 (Fig 3,6,7). 335 
Interestingly the BEV encoded PDE was able to antagonize RNase L and rescue virus MHVMut 336 
replication both in vitro and in vivo despite the apparently low level of expression (Fig 5,6,7). 337 
This is not surprising as MERS NS4b PDE can rescue MHVMut despite its very low expression 338 
level in the cytoplasm (6). PHEV NS2, is less enzymatically active than the other PDEs (Fig 3), 339 
suggesting it may be less able to antagonize RNase L. However since we could not detect 340 
expression by western blot of the PHEV PDE from a chimeric virus (Fig 5), further work will be 341 
needed to determine if it has RNase L antagonist activity in the context of an infection. 342 
Interestingly both the BEV and PHEV PDEs are truncated at the carboxytermini similar to the 343 
rotavirus PDE [Fig 3; (14)]; clearly the carboxyterminal sequences are not required for cleavage 344 
of 2-5A or RNase L antagonism as the rotavirus VP3-CTD and BEV  PDEs have similar activity 345 
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to the other PDEs, suggests that while PDE may have been essential in the PHEV ancestor, it 347 
may not be required in the cells targeted by PHEV in its porcine host. However, RNase L is 348 
likely actively antiviral in other porcine tissues or stages of development, as suggested by the 349 
presence of an RNase L antagonist in protein 7 of transmissible gastroenteritis virus (24).  350 
 351 
Although the chimeric MHVs encoding OC43-NS2 and BEV pp1a-CTD do not replicate quite as 352 
well as MHV in vivo (Fig. 6), this is unlikely due to disruption of the ORF4 gene by insertion of 353 
the exogenous PDEs as ablation of ORF4 expression within the genome of MHV strain JHM, 354 
had no effect on replication in vitro and in vivo pathogenesis and the MHV strain A59 ORF 4 is 355 
disrupted by a termination codon (25). Nevertheless, these chimeric viruses replicated robustly 356 
in vivo causing hepatitis and their respective mutants replicated to wild-type titers in the livers of 357 
RNase L-/- mice, indicating that restriction of the mutants in WT B6 mice is due to RNase L 358 
activity.  359 
 360 
Overall, we have demonstrated that active 2’,5’ PDEs are a conserved feature of lineage A 361 
Betacoronavirus genomes, and that a homologous domain is encoded in the first open reading 362 
frame of a related nidovirus, BEV. This suggests that RNase L is a potent antiviral effector in 363 
diverse species and tissues, due to the wide host range represented by the viruses encoding 364 
these now-characterized PDEs. This thus far includes the lineage A and lineage C 365 
betacoronaviruses as well as the related toroviruses and the unrelated group A Rotaviruses 366 
(4,14). Finally since 2’,5’-PDEs are potent antagonist of host antiviral defenses encoded by 367 
multiple and diverse viruses within Coronaviridae, this class of protein may have the potential to 368 
be a broad-spectrum therapeutic target for human viruses including the OC43, a ubiquitous 369 
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Figure Legends 473 
Fig 1. Alignment of lineage A betacoronavirus  and Berne torovirus PDEs.  PDEs with Genbank 474 
assession numbers are MHV NS2 (P19738.1) (26), OC43 NS2 (AAT84352.1) (27), HECoV NS2 475 
(ACJ35484.1),   ECoV NS2 (ABP87988.1) (28), PHEV NS2 (AAY68295.1) (29) and BEV 476 
(CAA36600.1) (30). Conserved catalytic HxS/Tx motifs are indicated by boxes. 477 
 478 
Fig 2. Known and predicted structures of nidovirus PDEs. (A) Crystal structure of MHV NS2 (PDB: 479 
4Z5V) and predicted structures of OC43 NS2 (B) and BEV pp1a-CTD (C). Predicted structures were 480 
generated using Phyre2 then visualized and annotated using UCSF Chimera 1.8. Catalytic His and 481 
conserved Ser/Thr residues are indicated. 482 
 483 
Fig 3. Assay of PDE activity of coronavirus and torovirus PDEs. Recombinant WT and mutant PDEs  484 
were incubated with 2-5A for 60 minutes and the remaining substrate was quantified using an 485 
indirect FRET based assay as described in Materials and Methods.  RFU= relative fluorescence 486 
units, is proportional to 2-5A remaining. Data shown are from one representative of three 487 
independent experiments, each carried out in triplicate with separate enzyme preparations and are 488 
expressed as means ± SEM; *, P < 0.05, **, P < 0.01, ***, P < 0.001. 489 
 490 
Fig 4. NS2 organization and construction of chimeric viruses. (A) Depiction of the NS2 protein of 491 
HCoV-OC43. Shown are the catalytic His residues at positions 49 and 129, with the His->Arg 492 
mutation shown below. (B) Genome organization of MHV with NS2 and NS4 loci indicated. Also 493 
shown are replicase open reading frames 1a and 1b, genes encoding structural proteins HE, S, E, 494 
M, N and I as well as nonstructural protein 5a.  In chimeric viruses MHV NS2 residue 126 is mutated 495 
from H->R, rendering NS2 catalytically inactive  (NS2Mut). The gene encoding the exogenous PDE 496 
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Fig 5. Expression of exogenous PDEs from chimeric viruses. L2 cells were infected with MHV or 499 
chimeric viruses and protein harvested 10 hpi and analyzed by western immunoblotting.  Blots were 500 
probed with  antibody against Flag to detect PDEs, anti-nucleocapsid  antibody to assess chimeric 501 
viral infection and GAPDH as a protein loading control. MHV NS2 (lanes 1-2) is not Flag-tagged. 502 
Flag-tagged WT and mutant PDEs of OC43, HECV, PHEV, ECoV and BEV are detected as 503 
indicated. This blot was performed two times using proteins from independent infections with similar 504 
results. 505 
 506 
Fig 6. Replication and activation of RNase L of chimeric viruses in bone marrow derived 507 
macrophages (BMM). (A-E) BMMs derived from WT B6 or RNase L-/- mice were infected with (A) 508 
MHV  or chimeric MHV viruses expressing WT or mutant (B) OC43 NS2, (C) HECoV NS2, (D) 509 
ECoV NS2 and (E) BEV pp1a-CTD.  Virus at each time point was titrated by plaque assay. Each 510 
time point is represented by three biological replicates, titrated in duplicate and variance expressed 511 
as SEM. Statistical significance was calculated by 2-way ANOVA in GraphPad Prism. **, P <0.01; 512 
***, P <0.001. (F) Total RNA was isolated from WT B6 BMMs 9 hpi and rRNA integrity assayed using 513 
an Agilent BioAnalyzer. These data are from one of at least two independent experiments with 514 
similar results  515 
 516 
Fig 7. Replication and pathogenesis of chimeric viruses in vivo. (A-C) WT B6 or RNase L-/- mice (n= 517 
5-7) were infected intrahepatically with (A) MHV and MHVMut or chimeric viruses encoding WT or 518 
mutant (B) OC43 NS2 or (C) BEV pp1a-CTD. Five days post-infection livers were harvested and 519 
virus titrated by plaque assay. Each data point represents a single mouse liver, titrated in duplicate 520 
with variance expressed as SEM. Statistical significance determined by 1-way ANOVA in GraphPad 521 
Prism. ***, P <0.001. Liver sections from infected mice were stained with (D) H&E to identify hepatic 522 
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